EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond the needle: engineering and industrial insight on oral delivery devices for biologics

Mengxuan Ji, Yulan Lu, Kasandra Arcovio, Yuxuan Wang, Khuloud T Al-Jamal, John Bolodeoku, Antonio E Forte, Peng Ke, Ramesh Kumar Shanmugam, Mohamed A Alhnan

Journal of Controlled Release · 2026-11 · 399 · 115371

DOI: 10.1016/j.jconrel.2026.115371 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Mengxuan Ji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, …. Hauptthemen laut MEDLINE: Biological Products, Drug Delivery Systems. Die Arbeit nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of biologics has transformed disease treatment, yet their clinical use remains constrained by a reliance on parenteral administration. Oral delivery offers a more patient-friendly alternative, but its effectiveness is limited by a range of physiological and biochemical barriers. Recent advances in ingestible robotic devices provide a promising pathway for oral delivery of biologics by enabling controlled release and site-specific targeting. Yet despite this momentum, no device-enabled oral biologic has reached regulatory approval. This review surveys current robotic oral delivery technologies, classifying them according to their power and actuation strategies, mechanisms of mucus interaction or penetration, and target regions of the gastrointestinal system. For each category, we examine underlying design principles, along with key advantages and limitations. We also present an industrial perspective on development status and commercial potential, highlighting translational challenges related to manufacturing, regulatory approval, and clinical integration. This review investigates the underappreciated downstream consequences of early-stage engineering decisions on manufacturing scalability, regulatory classification, chronic biocompatibility, and cost of goods. Here, we evaluate translational viability by defining the engineering, pharmacokinetic, safety, and economic criteria that devices must simultaneously satisfy to advance beyond proof-of-concept.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsDrug Delivery SystemsHumansAdministration, OralAnimalsRobotics

Stichwörter der Autor:innen

Biological macromoleculesDrug deliveryIngestible robotic devicesOral biologicsSite-specific targetingTranslational barriers

Substanzen

Biological Products

Autor:innen und Institutionen

  • Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9NH, UK.
  • Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK.
  • Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9NH, UK; Department of Pharmacology and Pharmacy, Li Ka Shi…
  • Dosage Form Design & Development, AstraZeneca, The Discovery Centre (DISC), Biomedical Campus, 1 Francis Crick Ave, Trumpington, Cambridge CB2 0AA, UK.
  • Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9NH, UK. Electronic address: Alhnan@kcl.ac.uk.

Förderung

  • China Scholarship Council

Zitieren

APA

Ji, M., Lu, Y., Arcovio, K., Wang, Y., Al-Jamal, K. T., Bolodeoku, J., Forte, A. E., Ke, P., Shanmugam, R. K., & Alhnan, M. A. (2026). Beyond the needle: engineering and industrial insight on oral delivery devices for biologics. Journal of Controlled Release, 399, 115371. https://doi.org/10.1016/j.jconrel.2026.115371

Vancouver

Ji M, Lu Y, Arcovio K, Wang Y, Al-Jamal KT, Bolodeoku J, et al. Beyond the needle: engineering and industrial insight on oral delivery devices for biologics. Journal of Controlled Release. 2026;399:115371. doi:10.1016/j.jconrel.2026.115371

BibTeX
@article{Ji2026,
  author = {Ji, Mengxuan and Lu, Yulan and Arcovio, Kasandra and Wang, Yuxuan and Al-Jamal, Khuloud T and Bolodeoku, John and Forte, Antonio E and Ke, Peng and Shanmugam, Ramesh Kumar and Alhnan, Mohamed A},
  title = {Beyond the needle: engineering and industrial insight on oral delivery devices for biologics},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {399},
  pages = {115371},
  doi = {10.1016/j.jconrel.2026.115371}
}
Kostenlos starten →